Home » Topics » Regulatory » EMA

EMA
RSS

CHMP issues positive opinion on two variations for Velcade

July 2, 2013

Regorafenib recommended for approval in the E.U.

July 2, 2013

European CHMP recommends approval of two infliximab biosimilars

July 2, 2013

EMA recommends approval of two GSK cancer drugs

July 2, 2013

Approval of Lemtrada for relapsing remitting MS recommended in Europe

July 2, 2013

EryDex obtains orphan drug designation for ataxia telangiectasia in Europe

June 18, 2013

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

June 10, 2013

Bavarian Nordic's smallpox vaccine receives positive opinion from CHMP

June 4, 2013

Lucentis receives positive CHMP opinion in myopic choroidal neovascularization

June 4, 2013

European CHMP recommends approval of Teva's Lonquex

June 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...